Viagra's Phase IV Problems

01 Dec 1998

Executive Summary

Shattering all previous barriers for impotence, sales of {Viagra} soared to nearly $100 million its first month out. Most industry analysts and drug company executives expect {Viagra} will be a blockbuster for many years to come, but there is a contrarian view. Contrarians argue that signs of problems are already beginning to emerge.

Existing Subscriber? Sign in to continue reading.

New to In Vivo? Start a free trial today!

Table
View full table

Topics

Industries
BioPharmaceutical

Related Companies

Pfizer Inc.

ASK THE ANALYST
Email

Print
Bookmark
Share

Tags:

BioPharmaceutical

You must sign in to use this functionality

Authentication.SignIn.HeadSignInHeader

IV000854

Ask the Analyst is free for subscribers. Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel

IV000854

All set! This article has been sent to my@email.address.

All fields are required. For multiple recipients, separate email addresses with a semicolon.

Please Note: Only individuals with an active subscription will be able to access the full article. All other readers will be directed to the abstract and would need to subscribe.

Viagra's Phase IV Problems

Executive Summary

Topics

Related Companies

You must sign in to use this functionality

Authentication.SignIn.HeadSignInHeader

Register

Ask The Analyst

Email Article

Viagra's Phase IV Problems

Executive Summary

Related Content

Lilly Icos: A Complementary Alliance

Topics

Related Companies

You must sign in to use this functionality

Authentication.SignIn.HeadSignInHeader

Register

Ask The Analyst

Email Article

Sign In To Set a Search Alert